A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemiaJeffrey E. Lancet, Branimir I. Šikić, George E. Durán et al.|Leukemia Research|2008Cited by 51